In the BioHarmony Drug Report Database

"Preview" Icon

Naloxegol

Movantik, Moventig (naloxegol) is a small molecule pharmaceutical. Naloxegol was first approved as Movantik on 2014-09-16. It is used to treat constipation in the USA. It has been approved in Europe to treat constipation and opioid-related disorders. Movantik’s patents are valid until 2032-04-02 (FDA).

 

Trade Name

 

Moventig
 

Common Name

 

naloxegol
 

ChEMBL ID

 

CHEMBL2219418
 

Indication

 

constipation, opioid-related disorders
 

Drug Class

 

Narcotic agonists/antagonists (normorphine type)

Image (chem structure or protein)

Naloxegol structure rendering